Okabena Investment Services Inc. Purchases 2,788 Shares of Zebra Technologies Co. (NASDAQ:ZBRA)

Okabena Investment Services Inc. boosted its position in Zebra Technologies Co. (NASDAQ:ZBRA) by 6,195.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,833 shares of the industrial products company’s stock after purchasing an additional 2,788 shares during the period. Okabena Investment Services Inc.’s holdings in Zebra Technologies were worth $774,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Assenagon Asset Management S.A. lifted its stake in Zebra Technologies by 487.0% in the fourth quarter. Assenagon Asset Management S.A. now owns 64,202 shares of the industrial products company’s stock worth $17,548,000 after purchasing an additional 53,265 shares during the last quarter. Pinebridge Investments L.P. lifted its stake in Zebra Technologies by 72.0% in the fourth quarter. Pinebridge Investments L.P. now owns 21,569 shares of the industrial products company’s stock worth $5,896,000 after purchasing an additional 9,032 shares during the last quarter. Isthmus Partners LLC lifted its stake in Zebra Technologies by 11.5% in the fourth quarter. Isthmus Partners LLC now owns 41,366 shares of the industrial products company’s stock worth $11,307,000 after purchasing an additional 4,280 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Zebra Technologies by 4.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 308,010 shares of the industrial products company’s stock worth $84,188,000 after purchasing an additional 11,803 shares during the last quarter. Finally, Morningstar Investment Services LLC lifted its stake in Zebra Technologies by 92.3% in the fourth quarter. Morningstar Investment Services LLC now owns 79,611 shares of the industrial products company’s stock worth $21,921,000 after purchasing an additional 38,207 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Zebra Technologies Stock Performance

Shares of ZBRA stock opened at $301.37 on Friday. The firm has a market cap of $15.50 billion, a price-to-earnings ratio of 59.80 and a beta of 1.70. The company’s 50 day moving average is $305.62 and its 200 day moving average is $279.67. The company has a quick ratio of 0.56, a current ratio of 0.99 and a debt-to-equity ratio of 0.57. Zebra Technologies Co. has a 52-week low of $194.59 and a 52-week high of $328.70.

Zebra Technologies (NASDAQ:ZBRA) last released its quarterly earnings results on Tuesday, April 30th. The industrial products company reported $2.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.13 by $0.71. Zebra Technologies had a net margin of 5.99% and a return on equity of 13.05%. The business had revenue of $1.18 billion for the quarter, compared to analyst estimates of $1.15 billion. During the same period in the previous year, the company earned $3.59 earnings per share. The business’s revenue for the quarter was down 16.4% on a year-over-year basis. On average, sell-side analysts anticipate that Zebra Technologies Co. will post 10.76 EPS for the current fiscal year.

Insiders Place Their Bets

In other Zebra Technologies news, insider Michael Cho sold 1,657 shares of Zebra Technologies stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $320.51, for a total value of $531,085.07. Following the transaction, the insider now directly owns 3,809 shares of the company’s stock, valued at $1,220,822.59. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.06% of the company’s stock.

Analyst Upgrades and Downgrades

ZBRA has been the subject of several research analyst reports. Barclays initiated coverage on shares of Zebra Technologies in a research note on Tuesday, April 2nd. They set an “equal weight” rating and a $292.00 price target for the company. UBS Group lifted their price target on shares of Zebra Technologies from $340.00 to $368.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Robert W. Baird lifted their price target on shares of Zebra Technologies from $312.00 to $330.00 and gave the company an “outperform” rating in a research note on Wednesday, May 1st. Wolfe Research raised shares of Zebra Technologies from a “peer perform” rating to an “outperform” rating and set a $337.00 price target for the company in a research note on Monday, April 8th. Finally, StockNews.com raised shares of Zebra Technologies from a “sell” rating to a “hold” rating in a research note on Thursday, May 2nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Zebra Technologies currently has a consensus rating of “Hold” and an average target price of $323.36.

About Zebra Technologies

Zebra Technologies Corporation, together with its subsidiaries, provides enterprise asset intelligence solutions in the automatic identification and data capture solutions industry worldwide. It operates in two segments, Asset Intelligence & Tracking, and Enterprise Visibility & Mobility. The company designs, manufactures, and sells printers that produce labels, wristbands, tickets, receipts, and plastic cards; dye-sublimination thermal card printers that produce images, which are used for personal identification, access control, and financial transactions; radio frequency identification device (RFID) printers that encode data into passive RFID transponders; accessories and options for printers, including carrying cases, vehicle mounts, and battery chargers; stock and customized thermal labels, receipts, ribbons, plastic cards, and RFID tags for printers; and temperature-monitoring labels primarily used in vaccine distribution.